WeVote
Log In

Bill

Bill

HRES 1258

Expressing support for the designation of May 2026 as "National Brain Tumor Awareness Month".

119th Congress Introduced by Josh Gottheimer and 6 co-sponsors

The bill designates May 2026 as National Brain Tumor Awareness Month to raise public awareness, honor those affected, and promote collaborative research and advocacy.

Submitted in House
0
WeVote Research Nonpartisan
Bill Summary · HRES 1258

Summary of H.Res. 1258 (119th Congress, 2nd Session)

Title: Expressing support for the designation of May 2026 as “National Brain Tumor Awareness Month”

Purpose and intent

  • The resolution expresses the House of Representatives’ support for designating May 2026 as National Brain Tumor Awareness Month.
  • It aims to raise public awareness about brain tumors, honor those affected, and promote advocacy and collaboration in brain tumor research and treatment.

Key provisions and changes

  • Formal designation: Encourages official recognition of May 2026 as National Brain Tumor Awareness Month.
  • Public awareness: Urges increased public awareness of brain tumors, recognizing both individuals who have died from brain tumors and those currently living with the diagnosis.
  • Treatment and prognosis: Supports efforts to develop better treatments that improve quality of life and long-term prognosis for brain tumor patients.
  • Support for patients and families: Expresses support for individuals battling brain tumors and for their families, friends, and caregivers.
  • Collaborative research emphasis: Encourages a collaborative approach to brain tumor research, highlighting the importance of shared efforts among researchers, clinicians, patient advocates, and related organizations.

Who or what would be affected

  • Non-legislative impact: As a resolution, it does not create new laws or funding. Its primary effect is to recognize and promote awareness.
  • Stakeholders highlighted: Brain tumor patients and survivors, families and caregivers, the medical and research community, patient advocacy groups, and the general public.

Procedural and timeline aspects

  • Introduction date: May 4, 2026.
  • Primary sponsors: Representative Mike Quigley (for himself and Representative Michael McCaul).
  • Referral: Referred to the House Committee on Energy and Commerce.
  • Status: House resolution; no enacted funding or mandatory actions attached.
  • Observance: Encourages nationwide awareness activities during May 2026.

Context and background (as stated in the bill)

  • Estimates cited (as context within the resolution):
    • More than 108,000 individuals will be diagnosed with a primary brain tumor in the United States in the referenced year.
    • Over 1,000,000 Americans are living with a brain tumor.
    • Brain tumors are the leading cause of death from cancer among children under 14 and teens under 19; and the second-leading cause of death among young adults aged 15–39.
    • The average 5-year survival rate after a primary malignant brain tumor diagnosis is about 34.8%.
    • An estimated 18,350 people in the United States will die from a malignant brain tumor in 2026.
  • Emphasis on diversity of brain tumors (more than 100 types) and the unique challenges in treatment due to the brain’s complexity.

If you’d like, I can tailor this summary for a specific audience (e.g., policymakers, healthcare professionals, or patient advocacy groups) or provide a concise one-page brief.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.